Molekule Consulting

Molekule Biopharmaceutical Consulting offers pharmaceutical strategy, market intelligence, and consulting services.

[Molekule Consulting @MolekuleBio]

Check out my latest article: PBM De-Addiction: Pharma’s Pivot From Rebates to Access Sovereignty https://t.co/xw3eoF8eT0 via @LinkedIn

[Molekule Consulting @MolekuleBio]

Check out my latest article: Ozempic’s “Get a Mac” Revival: Defensibility as the Long Game in the GLP-1 Category https://t.co/ZkDH8AsaFe via @LinkedIn

[Molekule Consulting @MolekuleBio]

⚠️ China vs. U.S.: 730-Day Biotech Eclipse 🚨 @IAmBiotech (BIO) CEO to Senate: “It’s inevitable.”

CHINA 🇨🇳
🔬 7,100 trials (2024) · 1 every 74 min (Source: https://t.co/ic7Axks8Iu / NMPA-National Medical Products Administration / ITIF)

💉 $28B state funds · builds 10 @pfizers (Source: Five-Year Plan aggregates)

🧬 AI labs: national nukes, not experiments

U.S. 🇺🇸
✅ Leads IP, trust, approvals

📉 Slope eroding. Fast.

THE ASYMMETRY 🇨🇳 vs. 🇺🇸
🗣️ 🇺🇸 We debate pricing 🚀 🇨🇳 They deploy pipelines

⏳ 🇺🇸 We hold panels 🔗 🇨🇳 They lock chains

📉 🇺🇸 We quarter-chase 📈 🇨🇳 They century-seize

Biotech = Defense 🛡️

Control biology. Own power. Forge sovereignty.

📣 Where’s YOUR biology made? 🇨🇳 or 🇺🇸

#MolekuleConsulting DecisionVelocity #JPM2026 #Biotech #HUMINT #MetabolicSovereignty #Geopolitics @PhRMA @SenToddYoung @SenAlexPadilla @EricTopol @AdamFriedmanMD
@nytimes @WSJ @business @BusinessInsider @HarvardBiz @endpts @FiercePharma @FierceBiotech @GoldieChan @HelenLiangFX

[Molekule Consulting @MolekuleBio]

🚨 PROJECT MERCURY: FINANCE FELL FIRST. BIOPHARMA IS NEXT. 🚨

@OpenAI hired 100 + former @GoldmanSachs , @jpmorgan , and @MorganStanley bankers at $150 per hour to train AI to build IPO, M&A, and model decks. Morgan Stanley already runs pilots. Analyst layers are disappearing.

💡 The same pattern of corpus training and talent inversion that gutted Wall Street is now walking into pharma.

🧬 Biopharma sits on terabytes of clinical data, patents, and filings. AI platforms already deliver results:
• @exscientiaAI → AI-designed molecules in 12 months vs 5 years
• @RecursionPharma → 42 → 18 month discovery cycles
• @InsilicoMedicine → AI-discovered TB drug in Phase 2 (per Reuters)
• @benevolent_ai → 50 % faster target ID (company release)

⚙️ AI now dominates virtual screening, biomarker mapping, trial-failure prediction, and patent patterning.
But when it comes to off-record M&A whispers, CRO rifts, regulator moods, or board-level strategy drift, AI is blind.

🛰️ HUMINT sees what machines cannot.
The next frontier is hybrid: AI speed × human foresight.

📈 Executives: if your CI playbook doesn’t already fuse algorithmic patterning with verified HUMINT, you’re 90 days behind.

⚡ Move now:
1 | Run a 14-day hybrid pilot (AI synthesis + HUMINT validation)
2 | Benchmark latency, accuracy, ROI
3 | Rebuild your CI stack before competitors monetize your blind spots

🔥 Biopharma’s Project Mercury moment has arrived.
🧠 The firms that master hybrid intelligence will own the next decade of discovery.

#ProjectMercury #OpenAI #Biopharma #AI #DrugDiscovery #CompetitiveIntelligence #HUMINT #DecisionVelocity #MolekuleIntel

[Molekule Consulting @MolekuleBio]

🔥 17% WEIGHT-LOSS PILL UNLOCKS $100B OBESITY MARKET. NO NEEDLES. @novonordisk REDEFINES CARDIOMETABOLIC MEDICINE.

OASIS 1 + 4 Phase 3 Trials (3 000 + patients) | FDA-BOUND PROOF
💊 15.1 % average loss (68 weeks) = injectable Wegovy equivalent
🩺 16.6 % in Type 2 diabetes + cardiovascular cohorts
📉 HbA1c –1.5 % | Cholesterol –18 % | BP –8 mm Hg | ~ 90 % pill adherence vs ~ 60 % injections

70 million Americans now addressable. $20 billion revenue forecast by 2027.
• @EliLillyandCo 12 % loss ← Novo ≈ 40 % advantage
• Manufacturing capacity 2× by Q1 2026 = secured supply
• Ozempic transformed behavior | this redefines the market

Filed to @US_FDA | decision expected Q4 2025 (pending approval) | new OASIS-4 data presented October 2025 at ObesityWeek 2025.
Injection barriers eliminated. Adherence tripled.

The inflection point of cardiometabolic medicine | biotech’s decade-defining breakthrough.

#WegovyPill #ObesityRevolution #GLP1 #NovoNordisk #HealthTech2025 #CardiometabolicMedicine #DecisionGradeINTEL #BiotechCapital #WeightLossBreakthrough #PharmaInnovation #HealthcareTransformation #InvestmentOpportunity #FDA2025 #GLP1Revolution #ObesityCrisis #BiotechUnicorn

[Molekule Consulting @MolekuleBio]

🚨 #ESMO2025 REDEFINES ONCOLOGY // Data That Will Reset Clinical Practice 💥👇
1️⃣ BREAST REVOLUTION
@DaiichiSankyo x @AstraZeneca ENHERTU slashes recurrence 53% (HER2-low, DESTINY-Breast09)

67% pCR (HER2+, Destiny-Breast11)
Paradigm shift activated. 👑

2️⃣ BLADDER BREAKTHROUGH
@Merck x @Pfizer EV + KEYTRUDA (EV-303) halves death risk in cisplatin-ineligible
Perioperative power play. 🛡️
3️⃣ PROSTATE DOMINATION
@Novartis PSMAddition (Lu-177) DOUBLES rPFS in PSMA+ mHSPC
RLT era begins. ⚡
4️⃣ LUNG LEAP
@AstraZeneca osimertinib + chemo (MARIPOSA-2) extends PFS 35% in EGFR+ NSCLC
Front-line combo age arrives. 🌪️
5️⃣ ER+ EVOLUTION
@Roche giredestrant crushes resistance in high-risk ER+ (perimeter trial)
Endocrine future secured. 🔄

⚡ These data aren’t trends // they’re 2026’s label landscape.
🧬 Five trials from #ESMO2025 that will define FDA 2026 submissions 👇
💬 Which data set changes YOUR clinical practice most? Vote + TAG 3 ONCOLOGISTS 👇
🩷 ENHERTU
🩵 EV-Pembro
🟣 PSMAddition
🫁 Osimertinib
💊 Giredestrant
⬇️ Comment below + save this for your #JPM2026 prep.
History will call this the #ESMO that rewrote oncology’s code.
#OncologyRevolution #ESMO2025 #CancerBreakthroughs #PrecisionOncology #FDA2026 #Biopharma #BreastCancer #LungCancer #BladderCancer #ProstateCancer
Decision-Grade HUMINT | Molekule Consulting ⎔ #HUMINT #BiopharmaIntel

[Molekule Consulting @MolekuleBio]

Berlin Brandenburg Airport | October 16 2025 | 10:00 a.m. CET

Two colleagues meet in the taxi queue after a year apart.
“Wow, you look great. What’s your secret?”
Single-word reply: Mounjaro.

No brand context. None needed.
Because that word now functions as a passport, a password, a meme.

At ESMO 2025, in the very city that once walled East from West,
a new barrier has risen.
Metabolic. Algorithmic. Geopolitical.
No one needs to cross Checkpoint Charlie anymore.
The border now lives inside the bloodstream and the feed.

Mounjaro. Ozempic. Wegovy. Zepbound.
Different labels. One law.
Time is currency.
Body is data.
Capital is behavior.

This is Eco-Pharmaco-Politik.
Not a health trend. An infrastructure.
The same logic that powers TikTok now governs the clinic.
The same cadence that drives WeChat now rewires the West’s metabolism.
WhatsApp talks. WeChat monetizes.
DeepSeek learns. OpenAI optimizes.
Different platforms. Same empire of attention.

If the West (EU | UK | US) does not accelerate innovation,
it becomes a licensee of China-origin molecules.
The algorithm will prescribe before the doctor does.
The patent will follow the platform, not the lab.

Credit to @AlbertBourla at @pfizer for naming the gravity.

Innovation is the final act of sovereignty.

🧬 Metabolic Diplomacy is underway.
⚙ The Feed = The Factory = The Future.
📡 Berlin is no longer divided by concrete but by code.

⎔ Eco-Pharmaco-Politik | October 2025 | Molekule Intelligence

#GLP1 #Mounjaro #Ozempic #Wegovy #Zepbound #EcoPharmacoPolitik #BiotechSovereignty #MetabolicDiplomacy #Berlin #ESMO2025 #MolekuleIntelligence #PharmaGeopolitics #ChinaPharma #InnovationEconomy #DigitalMetabolism

[Molekule Consulting @MolekuleBio]

Check out our latest article: Beyond the Black Box: Biopharma's AI Obsession Has a Hallucination Problem https://t.co/VNXCiNXaSL via @LinkedIn

[Molekule Consulting @MolekuleBio]

When Molekule launched 13 years ago, “competitive intelligence” in biopharma was largely tactical. Conference tracking. Clinical trial databases. Occasional field force benchmarks.

Valuable, but reactive.

Since then, the stakes have changed. So have the questions. So have we.

At Molekule Consulting, we have spent more than a decade building a new standard: Strategic intelligence powered by high-fidelity, ethically sourced HUMINT.

What once sat at the edges of brand planning is now embedded in enterprise strategy. Today, CI is no longer just about who is presenting at ESMO or what is filed on https://t.co/ic7Axks8Iu. It is about:

***Anticipating M&A moves before they are announced

***Pressure-testing commercialization strategies across geographies

***Benchmarking entire functions, not just assets

***Interpreting policy drift, access dynamics, and regulatory positioning

***Simulating competitor moves well in advance of launch

We continue to execute the fundamentals with rigor. What clients rely on most is what comes before the data: insight that clarifies why something is happening, what it means, and how to act on it.

Recently, AI has entered the conversation and is widely described as the future of strategic knowledge. It is powerful. But it is only as good as the data it was trained on.

It can detect patterns. It can generate probabilities.

It cannot ask a question that has not yet been programmed. It cannot infer the motive behind a decision that has not yet been disclosed.

That remains the domain of HUMINT.

At Molekule, we believe in convergence, not substitution. We have operationalized that philosophy into a working model:

∫ (HUMINT + OSINT + SIGINT + AI) = SI

Strategic Intelligence is integration. Structured. Secure. Decision-ready.

That is what we have delivered for 13 years.

Not just data. Not noise.

Intelligence. Ethically sourced. Interpreted. Built for action.

To our clients, thank you for your trust.

To those raising the bar alongside us, we welcome the challenge.

To the next 13, we move forward with purpose.

Thank you!

#MolekuleTurns13 #StrategicIntelligence #HUMINT #AIandHumanInsight #BiopharmaStrategy #Commercialization #MarketAccess #MedicalAffairs #RegulatoryIntelligence #EnterpriseCI

[Molekule Consulting @MolekuleBio]

In April 2012, Molekule Consulting built the first HUMINT-based strategic intelligence service in hashtag#biopharma.

Precision. Intent. Durability.
Not a brand story—an operating system.
In December 2023, an impression appeared.
Partially formed. Visually familiar. Structurally hollow.
The distinction is visible in the brushstroke.
And unmistakable in the outcome.

Time-tested HUMINT cannot be replicated overnight.

Est. 2012. Still original. Still operational. Still Molekule Consulting.

#RealHUMINT #OriginalSince2012 #StrategicThoughtPartnership #StillMolekule #NoSecondActs

[Molekule Consulting @MolekuleBio]

In a world drowning in data but starving for insight, clarity is power.

At Molekule Consulting, we don’t just filter noise—we decode it. Our HUMINT-driven intelligence and AI-powered precision cut through the static to reveal what truly matters.

Because data without context is distraction. Intelligence without foresight is blind. You don’t need another report—you need a competitive edge, a strategic compass, a clear view of what’s next.

Molekule Consulting. See Clearly. Act Decisively.

#Biopharma #CompetitiveIntelligence #StrategicForesight #HUMINT #AIInsights #PharmaStrategy #MarketIntelligence #Biotech #GoToMarket #PharmaLeadership #NextGenIntelligence #SeeClearlyActDecisively #MolekuleConsulting

[Molekule Consulting @MolekuleBio]

Today is International Women’s Day, and before tipping my hat to the brilliant women of the wider world, let’s start exactly where life demands—with my fiercely determined daughter, Allison.

At eight-and-a-half (the half is critical—just ask her), she is already an unstoppable creative force, channeling equal parts charm, tenacity, and #Broadway-bound dramatics into every waking hour. Allison doesn’t just dance, sing, or write songs—she inhabits them. Seriously, if intensity were an Olympic sport, we’d already be shopping for medal display cases. #Juilliard Class of 2038, better reserve a corner suite now. 🎭✨

Allison tackles life’s complexities—social media minefields, playground geopolitics, and existential crises over missing stuffed animals—with humor, heart, and occasionally, very loud renditions of her original compositions at bedtime. Her infectious spirit, boundless curiosity, and steely determination echo perfectly in the extraordinary women at Molekule Consulting. These brilliant strategists, physicians, scientists, and analysts masterfully choreograph their way through disruption, transforming global health with intelligence, grace, and a healthy dose of “bring it on” bravado.

Today also belongs to two women who’ve shaped me profoundly—my mother and my wife. They’ve shown me empathy and strength aren’t just compatible—they’re inseparable, the heartbeat of real leadership. And yes, sometimes leadership means knowing exactly when to nod, smile, and admit you’re utterly outmatched (I’m well-practiced).

So here’s to Allison—future Broadway sensation, The Juilliard School’s incoming diva-in-residence circa 2038—and to all the inspiring women whose resilience, brilliance, and boundless humanity shape our shared future.

#InternationalWomensDay #IWD2025 #Juilliard2038 #MOLEKULEWomen #InspiredByWomen #FutureLeaders #WomenWhoLead #KeepUpIfYouCan 💪🎶✨

[Molekule Consulting @MolekuleBio]

ACTIONABLE. STRATEGIC. INTELLIGENCE.

Navigating the complex world of biopharma demands more than just data—it requires the integration of nuanced human intelligence (#HUMINT), deep analytical rigor (#OSINT & #SIGINT), and cutting-edge #AI to anticipate strategic opportunities and threats before they surface.

At Molekule Consulting, we've perfected this integration to give your biopharma business the competitive edge it needs.

Our unique approach combines deep industry insights (HUMINT), advanced analytics (AI), and precise strategic foresight (OSINT/SIGINT). The result? Clear, actionable intelligence enabling you to lead, not just compete.

If you’re ready to step beyond the ordinary into extraordinary strategic clarity and assert industry leadership, we're ready to partner.

Explore how Molekule can be your biopharma’s X-Factor:

👉 https://t.co/dXrz10dQgS

#Biopharma #CompetitiveIntelligence #StrategicInsights #AI #HumanIntelligence #PharmaInnovation #MolekuleConsulting

[Molekule Consulting @MolekuleBio]

In #BioPharma, an industry where success hinges on investing based on robust, evidence-based intelligence, our X-factor (Molekule.X.) is the ultimate game-changer.

At Molekule Consulting, we combine HUMINT, OSINT, SIGINT, and AI into one transformative formula: ∫ (HUMINT+OSINT+SIGINT+AI) = SI.

We don’t just gather #data; we tap into stakeholder insights—from trusted industry experts and key opinion leaders—to lay the groundwork for breakthrough strategies and competitive success.

By fusing these invaluable stakeholder insights with open-source intelligence, signals data, and advanced AI analytics, Molekule creates a dynamic blueprint that emplowering CI, strategy, and marketing professionals across biopharma to make bold moves and disrupt the status quo.

Elevate your strategy. Disrupt the norm. Unleash your X-Factor with Molekule.X.

Discover more at https://t.co/amyUwURGEs.

#MolekuleX #BoldMoves #EvidenceBased #DisruptTheStatusQuo #BioPharma #StrategicIntelligence #GameChanger #Pharma #AI #HUMINT

[Molekule Consulting @MolekuleBio]

AI Alone Won’t Win the Biopharma Race—Here’s Why.

AI is fast. Powerful. Transformative. It crunches numbers, predicts trial outcomes, and optimizes pipelines at a scale no human can match.

But here’s the reality: AI doesn’t make decisions. People do.

And in biopharma, success isn’t just about processing data—it’s about understanding the people, motivations, and market dynamics behind the decisions.

🔥 This is where HUMINT changes the game. 🔥

At Pharma CI Europe 2025, I will lead the discussion on intelligence that differentiates between following the trends and setting them:
Decoding Biopharma: Why Human Intelligence (HUMINT) Still Trumps AI Algorithms

❌ AI identifies patterns.
✅ HUMINT interprets intent.
❌ AI predicts outcomes.
✅ HUMINT anticipates decisions.
❌ AI processes numbers.
✅ HUMINT decodes strategy.

At Molekule Consulting (https://t.co/Kv7VceJo6U), we operate at the intersection of data and human intelligence—tracking competitor moves, uncovering the real drivers of pharmaceutical commercialization, and pinpointing the subtle shifts that signal opportunity (or risk).

📍 Munich. April 23-24, 2025. Join the conversation.

🚀 This isn’t just another hashtag#AI debate—it’s a deep dive into what truly moves markets.

💡 Let’s go beyond the data. Let’s decode the future.

🔥 Will you be there? Let’s talk. 🔥

hashtag#PharmaCIEurope hashtag#BiopharmaLeadership hashtag#HUMINT hashtag#AI hashtag#CompetitiveIntelligence hashtag#BiopharmaStrategy hashtag#LifeSciences hashtag#MolekuleConsulting hashtag#PharmaMarketAccess hashtag#PharmaCommercialStrategy hashtag#DrugDevelopment hashtag#PharmaInnovation hashtag#GoToMarketStrategy hashtag#BiopharmaTrends hashtag#PharmaFuture hashtag#HealthcareLeadership

[Molekule Consulting @MolekuleBio]

Ever wondered what it takes to succeed in consulting and competitive intelligence? Today, we’re excited to feature Shilpa Rawal, Ph.D, who shares her insights and experiences at Molekule Consulting!

🔹 What’s one skill you’ve developed or strengthened since joining Molekule?

“One of the key skills that I have strengthened is client management, ensuring a seamless experience by providing holistic and tailored solutions that align with client expectations and business goals. Internally, this involves collaborating with team members to ensure smooth and efficient implementation.

🔹 How do you stay connected with your team, especially in a hybrid or remote environment?

“Technology has made it easier to stay connected across time zones and collaborate effortlessly. The key is to proactively engage with teammates through regular check-ins and to have clear communication. This enables open discussions, brainstorming, collaboration and problem-solving, all while respecting everybody’s timelines.”

🔹 What trends or developments in consulting or the pharmaceutical space are you most excited about?

“The pharmaceutical and biotech industries are witnessing unprecedented innovation and AI is revolutionizing healthcare from diagnosis, drug discovery to clinical trials and patient engagement. AI-powered tools are redefining traditional competitive intelligence by analyzing vast datasets, generating real-time insights and identifying trends and streamlining monitoring. This integration of AI is improving efficiencies, optimizing resources and accelerating decision-making to maintain a competitive edge.

🔹 What inspired you to pursue a career in this field?

“I wanted a PhD in life sciences to create a meaningful impact in medicine. However, the long time from bench to bedside led me to pharma consulting, where I can make a real, tangible impact on people’s lives by supporting patient journeys and improving overall wellbeing.

Being strategic thought partners to clients enables us to contribute to critical decision-making through evidence-based insights, shaping drug development and commercialization strategies across various therapeutic areas. Seeing my recommendations influence the drug development process makes my career very fulfilling.”

🔹 Can you share a memorable project or accomplishment you’re particularly proud of?

“Nearly all my projects have been memorable involving the same level of dedication and hard work. To name a few:

- An infection diseases project where the client mentioned that we are one of the finest CI partners they’ve worked with.
- The underestimated women’s health project proved to be impactful.
- Cardiovascular and oncology projects, where our high-quality deliverables have led to continued partnerships year after year.

It’s also incredibly motivating to be recognized by the organization such as receiving the ‘Above & Beyond’ award in Q4 2021 earning three promotions in just 15 months!”

hashtag#Careers hashtag#Talent hashtag#Culture hashtag#Pharma

[Molekule Consulting @MolekuleBio]

Biopharma moves fast. Your intelligence needs to move faster.

🔍 Molekule delivers deep HUMINT + AI-driven intelligence so you can outmaneuver, outthink, and outperformin the race to market.

🚀 Decisions win markets. Get the intelligence that gives you the edge: https://t.co/dXrz10dQgS

#Biopharma #CompetitiveIntelligence #PharmaStrategy

[Molekule Consulting @MolekuleBio]

Proud Platinum Sponsor of Pharma CI USA & Europe!

Masterclass:
All-Domain Intelligence Synthesis for Ethical and Actionable Results

Keynote Presentation:
Empowering Global and Market Affiliate CI Teams

Connect with us:
[email protected]
https://t.co/rQb2uDE5R3

[Molekule Consulting @MolekuleBio]

Happy birthday America! We are thankful for our freedom and the ones who made it possible.

Today Molekule celebrates our unalienable rights – life, liberty, and the pursuit of happiness – with all that’s red, white, and blue.

Happy Independence Day!…https://t.co/1bIiCNFvr4

[Molekule Consulting @MolekuleBio]

On the road to successful competitive intelligence and sustainability, the Molekule team doesn’t just take you to your destination.

We also build the road and pave the way – with skilled staff at the helm of our advanced and robust data collection.

#int…https://t.co/xkowmxWLhK